Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Taraseviciene-Stewart, M. Hanaoka, D. Kraskauskas, N. Burns, M. Nicolls, N. Voekel (Denver, CO, United States Of America). Immune modulatory strategies for prevention of autoimmune emphysema. Eur Respir J 2007; 30: Suppl. 51, 4255

Member's Comments

No comment yet.

Related content which might interest you: Relevance of innate immune responses to chronic airway diseases Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences Year: 2008 Immune system dysregulation in chronic lung disease Source: Eur Respir J 2011; 38: 500-501 Year: 2011 Lymphoid interstitial pneumonia should be suspected in children with autoimmune disease and immune deficiency Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Early-life pulmonary immunity and development of paediatric inflammatory respiratory diseases Source: International Congress 2019 – Early origins of lung disease: an interdisciplinary approach Year: 2019 The adaptive immune system, autoimmunity and COPD: lessons from human studies Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 Immune reconstitution inflammatory syndrome associated with pulmonary pathogens Source: Eur Respir Rev 2017; 26: 160042 Year: 2017 Systemic inflammation and endocrinologic/metabolic implications of obesity Source: International Congress 2019 – Obesity: pathophysiology, diagnostic challenges and multidisciplinary treatment Year: 2019 Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Antiviral defences in chronic obstructive lung diseases Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases Source: Eur Respir Monogr 2017; 77: 224-246 Year: 2017 The adaptive immune system, autoimmunity and COPD: lessons from animal models Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Microbes mediated host innate immune response in idiopathic pulmonary fibrosis Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Systemic inflammation in COPD – a role for infection? Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Autoimmunity and pulmonary hypertension: a perspective Source: Eur Respir J 2005; 26: 1110-1118 Year: 2005